Viral Hepatitis Roundtable Applauds National AIDS Strategy's
Recognition of HIV/HCV Coinfection
The National Viral Hepatitis Roundtable (NVHR) praised
the inclusion of hepatitis B and C coinfection in
the White House Office of National
AIDS Policy's National HIV/AIDS Strategy released
last week, given that an about 30% of HIV
positive people also have HCV
and approximately 10% also have HBV.
The advocates also expressed hope that the administration
will take a similar comprehensive approach to hepatitis
B and C monoinfection, the latter of which affects
about 4 times as many people as HIV.
is the text of a press release issued by the National Viral
Administration's National HIV/AIDS Strategy
Recognizes Need for Better Care Coordination for
Individuals Co-Infected with Viral Hepatitis
DC -- July 14, 2010 -- With millions of Americans living with
HIV/AIDS, chronic viral hepatitis, or a combination of both,
the National Viral Hepatitis Roundtable (NVHR) welcomes the
Administration's recognition of the need for better care coordination
and integration of services for these individuals and supports
recommendations contained within the new National HIV/AIDS Strategy
released yesterday in Washington. As the Administration's interagency
working group on viral hepatitis works to meet an October 1,
2010 deadline for its own action plan, NVHR is hopeful that
we will see a similar national commitment from the Administration.
An estimated 5.3 million Americans are infected with chronic
viral hepatitis, which is 4 times the estimated HIV/AIDS population.
Chronic viral hepatitis is a leading cause of death in HIV patients
"NVHR welcomes the Administration's recognition of the
need for better care coordination for individuals afflicted
with HIV/AIDS," said Ms. Lorren Sandt, NVHR Chair and Executive
Director of Caring Ambassadors Program, based in Portland, OR.
"With approximately 30 percent of all individuals living
with HIV/AIDS co-infected with hepatitis C and 10 percent co-infected
with hepatitis B, an integrated, comprehensive strategy is critical
if we are going to win the war against these insidious diseases.
The outdated 'silo' approach undermines quality and leads to
higher costs throughout the system."
The Administration's national HIV/AIDS strategy provides a model
for how to galvanize the entire public health infrastructure
into action. With policymakers, clinicians, and others stakeholders
seeking to transform our system into one based on preventive
care, early intervention to screen, detect, and treat viral
hepatitis is essential. With most Americans unaware they are
infected, chronic viral hepatitis progresses far too often to
liver cancer, cirrhosis, or liver failure. Delayed screening
and treatment leads to billions of dollars in avoidable health
care costs. Milliman estimates that public and private payers'
cost of treating chronic viral hepatitis C alone will more than
triple by 2024 to $85 billion unless Washington acts. While
proposed legislation would help address this crisis, NVHR believes
more needs to be done.
"Just like yesterday's HIV/AIDS announcement, the viral
hepatitis plague demands leadership from the highest levels
of the federal government," added Ms. Sandt. "Otherwise,
millions of Americans will be at risk of developing life-threatening
NVHR is a coalition of more than 150 public, private, and voluntary
organizations dedicated to reducing the incidence of infection,
morbidity, and mortality from chronic viral hepatitis that afflicts
more than 5 million Americans.
more information, see www.nvhr.org.
Viral Hepatitis Roundtable. NVHR: Administration's National
HIV/AIDS Strategy Recognizes Need for Better Care Coordination
for Individuals Co-Infected with Viral Hepatitis. Press release.
July 14, 2010.